Recent Articles from GlobeNewswire

SANTA CLARA, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced it has entered into a definitive agreement to sell ZT Systems’ U.S.-headquartered data center infrastructure manufacturing business to Sanmina (NASDAQ: SANM), a leading integrated manufacturing solutions company. As part of the transaction, Sanmina becomes a preferred new product introduction (NPI) manufacturing partner for AMD cloud rack and cluster-scale AI solutions. AMD will retain ZT Systems’ world-class design and customer enablement teams to accelerate the quality and time-to-deployment of AMD AI systems for cloud customers.

WASHINGTON, May 19, 2025 (GLOBE NEWSWIRE) --  FTI Consulting, Inc. (NYSE: FCN) today announced that B. Douglas Bernheim, the Edward Ames Edmonds Professor of Economics at Stanford University, has affiliated with its subsidiary Compass Lexecon.

TORONTO, May 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that after receiving approval from the Board of Directors, the Company has purchased an additional USD $1,000,000 worth of Bitcoin (BTC) and other cryptocurrencies as part of its strategic efforts. This brings the total amount of BTC and other cryptocurrencies purchased to USD $4,500,000. As previously announced the company will continue to allow for future financing and other transactions to be carried out in cryptocurrency.

-- Enrollment Completed on Schedule; Topline Results Expected Q3 2025 --

First XLRS study to demonstrate efficacy and positive safety data in a Phase I/II trial

PARIS, May 19, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This program creates an expedited review pathway for devices that have the potential to provide more effective treatment for life-threatening or debilitating conditions and meet FDA’s rigorous standards for safety and efficacy.

Purchase is subject to bankruptcy court and regulatory approvals

Regeneron Commits to Comply with Company’s Privacy Policy and All Applicable Law; No Changes to 23andMe’s Privacy Policy or Consumer Genome Services

PECOS, Texas, May 19, 2025 (GLOBE NEWSWIRE) -- Electric Hydrogen, an American manufacturer of high-power electrolyzer plants, announced today that Infinium, a leading producer of commercial eFuels, has selected Electric Hydrogen’s 100 megawatt (MW) HYPRPlant for its large-scale eFuels facility in Texas, Project Roadrunner.

Continued momentum in sales to Tier-1 defense manufacturers gearing up for program of record deliveries for end users including the U.S. Department of Defense (DoD) and other major world militaries

CHICAGO, May 19, 2025 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), a carbon management solutions company, today reported its financial and operating results for the first quarter of 2025.

PHOENIX, May 19, 2025 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported first quarter fiscal 2025 financial and operating results.

LONDON and NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases, announced that its CEO, Gary S. Jacob, Ph.D., will be giving an oral presentation at the 4th Annual GPCRs-Targeted Drug Discovery Summit in Boston, MA on May 22, 2025. Dr. Jacob’s presentation will cover the development of urcosimod, OKYO’s lead clinical drug candidate, to treat neuropathic corneal pain (NCP) which is a debilitating condition affecting many tens of thousands worldwide, and is characterized by chronic, severe eye discomfort.

First-in-human study will evaluate safety, tolerability, and early efficacy of a one-time, pancreas-targeted smart GLP-1TM gene therapy for patients with inadequately controlled T2D and obesity

Honoring Innovation in Edutainment and STEAM Experiences for Kids

ZUG, Switzerland, May 19, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced the acceptance of abstracts for presentation at three upcoming congresses: the 14th C1-Inhibitor Deficiency and Angioedema Workshop, to be held from May 29-June 1, 2025, in Budapest; the 2025 Eastern Allergy Conference (EAC), to be held from May 29-June 1, 2025, in Palm Beach, Fl.; and the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, to be held from June 13-16, 2025, in Glasgow.

Fragrance maintains its position as the top-performing category

Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program

The annual analysis documented approvals of 18 new personalized medicines in 2024, important regulatory milestones and establishment of the Center for Drug Evaluation and Research AI Council

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Open Lending Corporation (“Open Lending” or the “Company”) (NASDAQ: LPRO) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ: DMRC) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

DALIAN, China, May 19, 2025 (GLOBE NEWSWIRE) -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) (“CBAK Energy,” or the “Company”) a leading lithium-ion battery manufacturer and electric energy solution provider in China, today reported its unaudited financial results for the first quarter ended March 31, 2025.

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Ibotta, Inc. (“Ibotta” or the “Company”) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

HOUSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (NYSE: AMPY) (“Amplify” or the “Company”) today announced that it has appointed Clint Coghill to its Board of Directors (the “Board”) as Lead Independent Director, effective May 16, 2025. In connection with Mr. Coghill’s appointment, the Company entered into a cooperation agreement with Mr. Coghill and his affiliates Stoney Lonesome HF, LP and The Drake Helix Holdings, LLC (collectively, “Stoney Lonesome”), the beneficial owners of approximately 7% of the Company’s outstanding shares.

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds NET Power Inc. (“Net Power” or the “Company”) (NYSE: NPWR) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Compass Group Diversified Holdings, LLC, and Compass Diversified Holdings (“Compass” or the “Company”) (NYSE: CODI) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

MARLBOROUGH, Mass., and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward, Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Larry Jasinski, Chief Executive Officer, will make a corporate presentation and host one-on-one meetings with investors at the Sidoti May Virtual Investor Conference, taking place on May 21-22, 2025. Joining him will be Mike Lawless, Chief Financial Officer.

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) (NYSE: BBAI) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Viatris, Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

GUANGZHOU, China, May 19, 2025 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading Urban Air Mobility (“UAM”) technology platform company, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2025 on Monday, May 26, 2025, before the U.S. market opens.

Qinshift and Avenga unite under one brand, strengthening global capabilities in AI, custom software development, and enterprise technology

LONDON, May 19, 2025 (GLOBE NEWSWIRE) -- Airtory proudly announces the launch of AdCTV, its new and improved CTV Ad Builder, developed to become the world’s leading platform for Connected TV advertising. Purpose-built by Airtory to simplify and accelerate the creation of Rich Media CTV and Display ad creation, AdCTV enables advertisers to build high-impact, interactive creatives faster and more efficiently than ever before. With its innovative features and streamlined interface, AdCTV empowers advertisers to create stunning, high-performance CTV creatives that seamlessly run across any CTV environment.

SHENZHEN, China, May 19, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its total revenues for the first quarter of 2025 is estimated to be in the range of approximately RMB87.0 million to RMB90.0 million, representing a year-over-year growth of approximately 35% to 40%. Previous revenue guidance was in the range of RMB74.0 million to RMB77.5 million.

TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it has commenced tender offers (the “Offers”) to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2,000,000,000 (equivalent) (the “Total Maximum Amount”) of the following series of notes issued by finance subsidiaries of Teva and guaranteed by Teva:

TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today its intention to issue $2,000,000,000 (equivalent) of senior notes through its special purpose finance subsidiaries. Teva Pharmaceutical Finance Netherlands II B.V. (“Teva Finance II”) intends to offer EUR-denominated Senior Notes (the “Euro Notes”) and Teva Pharmaceutical Finance Netherlands III B.V. (“Teva Finance III”) and Teva Pharmaceutical Finance Netherlands IV B.V. (“Teva Finance IV” and, together with Teva Finance II and Teva Finance III, the “Issuers”) intend to offer USD-denominated Senior Notes (the “USD Notes” and, together with the Euro Notes, the “Notes”).

OR YEHUDA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Magic Software Enterprises Ltd. (Nasdaq and TASE: MGIC) (“Magic Software” or the “Company”), a global provider of IT consulting services and end-to-end integration and application development platforms solutions, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the “SEC”) on Wednesday, May 14, 2025. The annual report on Form 20-F, which contains Magic Software’s audited annual financial statements for 2024, can be accessed on the SEC’s website at http://www.sec.gov, as well as via the Company’s investor relations website at https://www.magicsoftware.com/investors/annual-reports/.

Xavier Chardon Appointed CEO of Citroën

May 19, 2025

-- First Quarter Revenues of RMB 682.0 million, increase 35.1% year over year

AI-powered capabilities help workplace teams get the right message to the right people, no matter where content starts or where employees work

SINGAPORE, May 19, 2025 (GLOBE NEWSWIRE) -- UP Fintech Holding Limited (“UP Fintech” or the “Company”) (NASDAQ: TIGR), a leading online brokerage firm focusing on global investors, today announced that it will report its financial results for the first quarter ended March 31, 2025, before the U.S. market opens on May 30, 2025.

        

        

OR YEHUDA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Formula Systems (1985) Ltd. (Nasdaq and TASE: FORTY) (“Formula” or the “Company”), a global information technology group engaged, through its subsidiaries and affiliates, in providing software consulting services and computer-based business solutions and developing proprietary software products, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the “SEC”) on Wednesday, May 14 2025. The annual report on Form 20-F, which contains Formula’s audited annual financial statements for 2024, can be accessed on the SEC’s website at http://www.sec.gov, as well as via the Company’s investor relations website at https://www.formulasystems.com/en/financial-reports.

Extending full telemetry, natural language querying, and analytic engine access to mobile devices for real-time IT operations and decision-making

Advanced Process Technologies, Packaging, and Design Flow

ST HELIER, Jersey, May 19, 2025 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) ("Caledonia" or "the Company") announces that it received notification on May 16, 2025 from Mr Victor Gapare, an executive director of Caledonia and the settlor of a discretionary trust which ultimately owns the shares in Toziyana Resources Limited, the largest shareholder in the Company, (“Toziyana”) that Toziyana has purchased, in aggregate, 12,449 common shares in the Company on May 15, 2025 at a volume weighted average price of $14.47 per share (the “Purchases”).

The company's Chief Technology Officer Niko Haatainen will take charge of the AI Lab and Peter Sarlin will invest in the company.

PRESS RELEASE

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced that members of the management team will participate in two upcoming investor conferences.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  TechTarget, Inc. (“TechTarget” or the “Company”) (NASDAQ: TTGT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

CHARLOTTE, N.C. and LUSAKA, Zambia, May 18, 2025 (GLOBE NEWSWIRE) -- Terra Metals Inc. is proud to announce the appointment of its Co-Founder and Co-Chairman, Mr. Mumena Mushinge, to the Baushi Royal Foundation (BRF)—a respected heritage organization representing 12 traditional Chiefs and Chiefdoms across Luapula Province, Zambia.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) and certain officers.   The class action, filed in the United States District Court for the Eastern District of Virginia, and docketed under 25-cv-00861, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Strategy securities between April 30, 2024 and April 4, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Canopy Growth Corporation (“Canopy” or the “Company”) (NASDAQ: CGC) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-01877, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Canopy securities between May 30, 2024 and February 6, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Northrop Grumman Corporation (“Northrop Grumman” or the “Company”) (NYSE: NOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  New Fortress Energy Inc. (“New Fortress” or the “Company”) (NASDAQ: NFE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Flowco Holdings Inc. (“Flowco” or the “Company”) (NYSE: FLOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Amerant Bancorp Inc. (“Amerant” or the “Company”) (NYSE: AMTB).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Biohaven Ltd.  (“Biohaven” or the “Company”) (NYSE: BHVN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) (NYSE: BBAI) and certain officers.   The class action, filed in the United States District Court for the Eastern District of Virginia , and docketed under 25-cv-00623, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired BigBear securities between March 31, 2022 and March 25, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADTRAN Holdings, Inc. (“ADTRAN” or the “Company”) (NASDAQ: ADTN).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Backblaze, Inc. (“Backblaze” or the “Company”) (NASDAQ: BLZE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bakkt Holdings, Inc. (“Bakkt” or the “Company”) (NYSE: BKKT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Take-Two Interactive Software, Inc. (“Take-Two” or the “Company”) (NASDAQ: TTWO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.